Tag: Hepatitis
Experimental Drug Combo Shows Success in HCV Treatment
Drug trio could join newer, highly-effective meds such as sofosbuvir, ledipasvir/sofosbuvir
Prednisolone, Pentoxifylline Little Use in Alcoholic Hepatitis
Nonsignificant drop in 28-day mortality with prednisolone; no improvement with pentoxifylline
Statin Use Found Beneficial in Hepatitis C Treatment
Improved virologic response rates, decreased liver fibrosis progression, HCC incidence
Inexpensive Antihistamine Repurposed to Focus on HCV
Lab tests suggest over-the-counter antihistamine could offer alternative to pricey new drugs
FDA Warns Against Amiodarone Use With Hepatitis C Meds
Adding ledipasvir/sofosbuvir or sofosbuvir to amiodarone could cause symptomatic bradycardia
Outcomes Favorable for HIV+ Kidney Transplant Recipients
However, survival rates lower if organ recipient also has hepatitis C
Vaccine May Provide Some Protection From Hepatitis E
Immunization offers nearly five years of protection, researchers say
High Prevalence of HCV in Baby Boomers Presenting to ER
Unrecognized HCV more likely among males, African-Americans, under/uninsured patients
CDC: Routine Procedures Lead to Two Cases of HCV Transmission
In both cases, there were breaches in safety rules, CDC reports
SVR Rates Up With New Regimens for HCV and HIV Coinfection
Studies show high rates for all-oral, interferon-free 3D plus ribavirin regimen, ledipasvir + sofosbuvir
